ExodusPoint Capital Management, LP
Position in TGTX — Tg Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,038,344
+$4,242,363 QoQ
Shares Held
164,513
+2.3% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#75
of 420 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Mar 31, 2024CallValue
$4,563,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. TGTX ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
This page
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in TGTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,038,344 | 164,513 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $4,795,981 | 160,885 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $3,168,042 | 80,346 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $6,509,483 | 278,302 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,592,091 | 1,101,298 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,541,814 | 561,592 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $4,563,000 | 300,000 | Call | Sole | 2024-05-14 | |
| 2023-12-31 | $926,248 | 54,230 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,631,596 | 195,167 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,866,296 | 155,648 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $354,417 | 23,565 | Shares | Other | 2023-05-11 | |
| 2022-09-30 | $805,244 | 136,021 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $224,625 | 52,853 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $462,471 | 48,630 | Shares | Other | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||